5 months in to Min/Fin Oral 1.3mg treatment. Hair-loss slowed/stopped Is this regrowth? 2/19/2026
Hair loss has slowed or stopped after 5 months of daily oral minoxidil and finasteride treatment, with ketoconazole shampoo used twice a week. Noticeable thickening is observed, especially on the mid scalp.
View this post in the Community →
Similar Community Posts Join
6 / 6 results
community 25M: Hair Thinning Despite 2 Years of Oral Minoxidil & DHT Blocker Use
A 25-year-old is experiencing hair thinning despite using oral minoxidil, finasteride, and dutasteride, and is considering adding topical minoxidil. They also have seborrheic dermatitis and are advised to try ketoconazole shampoo or cream and possibly CBD with MCT oil.
community Day 55 of minoxidil and finasteride
A 20-year-old is using oral and topical finasteride, topical minoxidil, ketoconazole shampoo, rosewater, Adgain tablets, creatine, and derma stamping to address hair loss. There is a debate about creatine's impact on hair loss, with some suggesting it increases DHT, while others disagree.
community Effectiveness of Topical Finasteride with Low DHT Levels and Oral Minoxidil
The user is considering using topical finasteride for hairline recession and thinning, despite having low DHT levels and previous side effects from oral finasteride. They are also taking 2.5 mg of oral minoxidil, which has not resulted in regrowth or stabilization.
community 6,5 months on oral finasteride 1mg, oral minoxidil 5mg daily, with ketokonazole shampoo and dermarolling every other week.
Significant hair regrowth was achieved using oral finasteride 1mg, oral minoxidil 5mg daily, ketoconazole shampoo, and dermarolling. It is advised to continue this regimen for 12-18 months before considering any changes.
community Would you say I’m on the right track? I’ve been on oral minoxidil 1.5mg, oral finasteride 1.25mg, and 2% ketoconazole cream for 4 months.
The user has experienced significant hair regrowth in 4 months using oral minoxidil, oral finasteride, and 2% ketoconazole cream. They are advised to continue the treatment, keep hair short, and be patient for further progress.
community 1.5 Months on Finasteride and Oral minoxidil
The user has been using 1.25mg Finasteride, 5mg Oral Minoxidil, Ketoconazole shampoo, and dermastamping for 1.5 months, noticing thicker hair and less scalp visibility, though changes are more noticeable in photos than in real life. They experienced no side effects from Finasteride but had initial chest discomfort with Oral Minoxidil, which resolved, and they plan to continue updating on their progress.
Related Research
6 / 6 resultsresearch Treatment of Hyperandrogenic Alopecia in Women
Hair loss in women can be treated with hormone therapy.
research Addressing Androgenetic Alopecia-A Complex Disorder-with a Multilateral Treatment Strategy
This review discusses recent advancements in understanding the pathophysiology of androgenetic alopecia and highlights the potential for multilateral topical therapies to improve treatment efficacy with fewer side effects; it reports no new clinical results.
research Comparative Efficacy of Various Treatment Regimens for Androgenetic Alopecia in Men
This study found that combining oral finasteride with topical minoxidil resulted in the greatest improvement in hair growth for male patients with androgenetic alopecia, compared to using any single treatment.
research Androgenetic, Diffuse and Senescent Alopecia in Men: Practical Evaluation and Management
This review discusses the evaluation and management of male baldness and related conditions, but reports no new clinical results.
research Entendendo a alopecia androgenética Understanding androgenetic alopecia Educação Médica Continuada
This study discusses the physiopathogeny, clinical manifestations, and treatment objectives of androgenetic alopecia without reporting new clinical findings.
research Managing patterned hair loss – a hair raising task!
This review summarizes existing knowledge on diffuse and patterned alopecia, emphasizing recent advancements in treatment beyond FDA-approved options, but it reports no new clinical findings.